Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney

Onkologie

Volumn 32, Issue 1-2, 2009, Pages 44-46

  Ansari, Jawaher ^a,b   Fatima, Arfeen ^a   Chaudhri, Shalini ^a   Bhatt, Rupesh I ^a   Wallace, Michael ^a   James, Nicholas D ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Bellini's duct carcinoma; Collecting duct carcinoma; Sorafenib; Tyrosine kinase inhibitors

Indexed keywords

SORAFENIB;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; METASTASIS; NEPHRECTOMY; PALLIATIVE THERAPY; SCAPULA; TREATMENT RESPONSE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; PYRIDINES; TREATMENT OUTCOME;

EID: 60249086902     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000183736     Document Type: Article

References (12)

1. Dobrońki P, Czaplicki M, Koźmińska E, Pykało R: Collecting (Bellini) duct carcinoma of the kidney-clinical, radiologic and immunohistochemical findings. Int Urol Nephrol 1999;31:601-9.
2. Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thiounn N, Dufour B: Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma? J Urol 2003;169:1287-90.
3. Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson CN, Neumann RD: Collecting duct carcinoma of the kidney. Hum Pathol 1990;21:449-56.
4. Pickhardt PJ, Siegel CL, McLarney JK: Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol 2001;176:627-33.
5. Dimopoulos MA, Logothetis CJ, Markowitz A, Sella A, Amato R, Ro J: Collecting duct carcinoma of the kidney. Br J Urol 1993;71:388-91.
6. Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Orsola I: Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma. Urology 2005;65:49-54.
7. Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, Medioni J, Banu A, Duclos B, Rolland F, Escudier B, Arakelyan N, Culine S: Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. J Urol 2007;177:1698-702.
8. Milowsky MI, Rosmarin A, Tickoo SK, Papanicolaou N, Nanus DM: Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature. Cancer 2002;94:111-6.
9. Gollob JA, Upton MP, DeWolf WC, Atkins MB: Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgery. Urology 2001;58:1058.
10. Peyromaure M, Thiounn N, Scotté F, Vieillefond A, Debré B, Oudard S: Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases. J Urol 2003;170:1138-40.
11. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM: Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356:125-34.
12. Procopio G, Verzoni E, Gevorgyan A, Mancin M, Pusceddu S, Catena L, Platania M, Guadalupi V, Martinetti A, Bajetta E: Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma. Oncology 2008;73:204-20.